Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Insmed, Inc. (NASDAQ: INSM).

Full DD Report for INSM

You must become a subscriber to view this report.


Recent News from (NASDAQ: INSM)

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
BRIDGEWATER, N.J., Dec. 04, 2018 (GLOBE NEWSWIRE) -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced the granting of inducement awards to two new employees. In accordance wi...
Source: GlobeNewswire
Date: December, 04 2018 08:30
Insmed to Present at Three November Conferences
BRIDGEWATER, N.J., Nov. 06, 2018 (GLOBE NEWSWIRE) -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced that management will participate in the following investor conferen...
Source: GlobeNewswire
Date: November, 06 2018 08:30
Insmed, Inc. (INSM) CEO William Lewis on Q3 2018 Results - Earnings Call Transcript
Insmed, Inc. (INSM) Q3 2018 Results Earnings Conference Call October 30, 2018, 08:30 AM ET Executives Blaine Davis - Vice President and Head of Investor Relations William Lewis - President and Chief Executive Officer Paolo Tombesi - Chief Financial Officer Roger Adsett - Chief ...
Source: SeekingAlpha
Date: October, 30 2018 11:30
Insmed misses by $0.08
Insmed (NASDAQ: INSM ): Q3 GAAP EPS of -$1.14 misses by $0.08. More news on: Insmed, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
Source: SeekingAlpha
Date: October, 30 2018 07:32
Insmed Reports Third Quarter 2018 Financial Results and Provides Business Update
—Quarter Highlighted by U.S. FDA Approval of ARIKAYCE ® (amikacin liposome inhalation suspension), Followed by Immediate Launch— BRIDGEWATER, N.J., Oct. 30, 2018 (GLOBE NEWSWIRE) -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to...
Source: GlobeNewswire
Date: October, 30 2018 07:30
Investor Expectations to Drive Momentum within Natural Resource Partners LP, Insmed, MagnaChip Semiconductor, Changyou, Pain Therapeutics, and Aurinia Pharmaceuticals - Discovering Underlying Factors of Influence
NEW YORK, Aug. 17, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Natural Resource Partners LP (NYSE:NRP), Insmed, Inc. (NASDAQ:INSM), Magn...
Source: GlobeNewswire
Date: August, 17 2018 07:35
Your Daily Pharma Scoop: Strongbridge And United Reports Positive, Insmed AdCom Favored
Stocks in News: SBBP, UTHR Strongbridge Bio's Recorlev successful in late-stage study; shares up 30% premarket Discussion : Strongbridge Biopharma plc ( SBBP ) announced positive results from a Phase 3 clinical trial of RECORLEV (levoketoconazole) in patients with endogenous Cushing...
Source: SeekingAlpha
Date: August, 12 2018 03:30
FDA Ad Com backs Insmed's ALIS for subpopulation of patients with NTM lung disease caused by MAC
An FDA advisory committee voted 12-2 yesterday in favor of the safety and effectiveness of Insmed's (NASDAQ: INSM ) ALIS (amikacin liposome inhalation suspension) for the treatment of adults with nontuberculous mycobacterial (NTM) lung disease caused by Mycobacterium avium complex (MAC) ...
Source: SeekingAlpha
Date: August, 08 2018 07:33

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-09-1419.7319.8820.2619.73324,965
2017-02-0214.9915.5915.8214.57513,111
2017-02-0114.8815.1115.1914.70277,672
2017-01-3113.9214.7714.8813.76512,054
2017-01-3014.6914.0414.9414.02591,977

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-1082,546103,62979.6553Short
2018-12-07100,883128,09578.7564Short
2018-12-06101,900143,24871.1354Short
2018-12-04154,256220,47169.9666Short
2018-12-03130,168212,41361.2806Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on INSM.


About Insmed, Inc. (NASDAQ: INSM)

Logo for Insmed, Inc. (NASDAQ: INSM)

Not available

 

Contact Information

 

 

Current Management

  • Thomas Whitten / President, CEO
  • Kevin Tully / Acting CFO

Current Share Structure

  • Market Cap: $2,155,408,816 - 05/17/2018
  • Issue and Outstanding: 76,623,136 - 04/30/2018

 


Recent Filings from (NASDAQ: INSM)

Amendment to the SC 13G filing
Filing Type: SC 13G/AFiling Source: edgar
Filing Date: August, 10 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: August, 02 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: August, 02 2018
Securities offered to employees under employee benefit plans
Filing Type: S-8Filing Source: edgar
Filing Date: May, 31 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 17 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 16 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 02 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 02 2018
Official notification to shareholders of matters to be brought to a vote (Proxy)
Filing Type: DEF 14AFiling Source: edgar
Filing Date: April, 05 2018
Additional proxy soliciting materials - definitive
Filing Type: DEFA14AFiling Source: edgar
Filing Date: April, 05 2018

 

 


Daily Technical Chart for (NASDAQ: INSM)

Daily Technical Chart for (NASDAQ: INSM)


Stay tuned for daily updates and more on (NASDAQ: INSM)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NASDAQ: INSM)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in INSM is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of INSM and does not buy, sell, or trade any shares of INSM. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/